Why do current safety systems sometimes fail to notice that approved drugs are causing serious adverse effects? And can surveillance methods be improved? Simon Frantz investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bresalier, R. S. et al. N. Engl. J. Med. 352, 1092–1102 (2005).
Mukherjee, D., Nissen, S. E. & Topol, E. J. J. Am. Med. Assoc. 286, 954–959 (2001).
Ray, W. A., Stein, C. M., Hall, K., Daugherty, J. R. & Griffin, M. R. Lancet 359, 118–123 (2002).
Graham, D. J. et al. Lancet 365, 475–481 (2005).
Jick, H., Kaye, J. A. & Jick, S. S. J. Am. Med. Assoc. 292, 338–343 (2004).
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
http://www.nature.com/doifinder/10.1038/434554a
http://www.nature.com/doifinder/10.1038/433790b
http://www.nature.com/doifinder/10.1038/432537a
http://www.nature.com/doifinder/10.1038/nrd1629
http://www.nature.com/doifinder/10.1038/nrd1560
http://www.nature.com/doifinder/10.1038/nrd1689
http://www.nature.com/doifinder/10.1038/nrd1517
Related external links
Rights and permissions
About this article
Cite this article
Frantz, S. Chasing shadows. Nature 434, 557–558 (2005). https://doi.org/10.1038/434557a
Published:
Issue date:
DOI: https://doi.org/10.1038/434557a
This article is cited by
-
The safety catch
Nature (2005)
